# Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)

> **NCT03939013** · NA · COMPLETED · sponsor: **Macfarlane Burnet Institute for Medical Research and Public Health Ltd** · enrollment: 634 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DIAGNOSTIC_TEST:** Xpert HCV VL

## Key facts

- **NCT ID:** NCT03939013
- **Lead sponsor:** Macfarlane Burnet Institute for Medical Research and Public Health Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-30
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-12-20
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2021-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03939013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03939013, "Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03939013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*